WO2021225212A1 - Analogue de viande - Google Patents
Analogue de viande Download PDFInfo
- Publication number
- WO2021225212A1 WO2021225212A1 PCT/KR2020/007791 KR2020007791W WO2021225212A1 WO 2021225212 A1 WO2021225212 A1 WO 2021225212A1 KR 2020007791 W KR2020007791 W KR 2020007791W WO 2021225212 A1 WO2021225212 A1 WO 2021225212A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- meat
- vegetable
- protein
- plant
- vegetable meat
- Prior art date
Links
- 235000013372 meat Nutrition 0.000 title claims abstract description 180
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 54
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 54
- 241000287828 Gallus gallus Species 0.000 claims abstract description 28
- 241000283690 Bos taurus Species 0.000 claims abstract description 26
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 21
- 239000003797 essential amino acid Substances 0.000 claims abstract description 21
- 235000020776 essential amino acid Nutrition 0.000 claims abstract description 21
- 235000013305 food Nutrition 0.000 claims abstract description 21
- 230000000840 anti-viral effect Effects 0.000 claims abstract description 12
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 11
- 235000013311 vegetables Nutrition 0.000 claims description 73
- 241000196324 Embryophyta Species 0.000 claims description 52
- 235000018102 proteins Nutrition 0.000 claims description 52
- 239000000203 mixture Substances 0.000 claims description 45
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 44
- 150000003278 haem Chemical class 0.000 claims description 30
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 29
- 235000013330 chicken meat Nutrition 0.000 claims description 27
- 238000004519 manufacturing process Methods 0.000 claims description 25
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 24
- 229930002875 chlorophyll Natural products 0.000 claims description 23
- 235000019804 chlorophyll Nutrition 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 20
- 229910052742 iron Inorganic materials 0.000 claims description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 12
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 12
- 239000011575 calcium Substances 0.000 claims description 12
- 235000001465 calcium Nutrition 0.000 claims description 12
- 108010073771 Soybean Proteins Proteins 0.000 claims description 11
- 241000282887 Suidae Species 0.000 claims description 11
- 229910052791 calcium Inorganic materials 0.000 claims description 11
- 229930003231 vitamin Natural products 0.000 claims description 11
- 235000013343 vitamin Nutrition 0.000 claims description 11
- 239000011782 vitamin Substances 0.000 claims description 11
- 229940088594 vitamin Drugs 0.000 claims description 11
- 235000015278 beef Nutrition 0.000 claims description 10
- 235000013312 flour Nutrition 0.000 claims description 10
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 9
- 241000335053 Beta vulgaris Species 0.000 claims description 9
- 235000019864 coconut oil Nutrition 0.000 claims description 9
- 239000003240 coconut oil Substances 0.000 claims description 9
- 235000015277 pork Nutrition 0.000 claims description 9
- 108010068370 Glutens Proteins 0.000 claims description 6
- 235000021312 gluten Nutrition 0.000 claims description 6
- 230000036737 immune function Effects 0.000 claims description 5
- 230000005764 inhibitory process Effects 0.000 claims description 5
- 229940001941 soy protein Drugs 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 abstract description 38
- 244000068988 Glycine max Species 0.000 abstract description 38
- 210000004369 blood Anatomy 0.000 abstract description 21
- 239000008280 blood Substances 0.000 abstract description 21
- 241000209140 Triticum Species 0.000 abstract description 17
- 235000021307 Triticum Nutrition 0.000 abstract description 14
- 238000002156 mixing Methods 0.000 abstract description 10
- 230000001747 exhibiting effect Effects 0.000 abstract description 4
- 102000001554 Hemoglobins Human genes 0.000 abstract description 2
- 108010054147 Hemoglobins Proteins 0.000 abstract description 2
- 235000005911 diet Nutrition 0.000 abstract description 2
- 230000037213 diet Effects 0.000 abstract description 2
- 235000019629 palatability Nutrition 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 27
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 20
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 20
- 241000209490 Nymphaea Species 0.000 description 16
- 235000016791 Nymphaea odorata subsp odorata Nutrition 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 235000014571 nuts Nutrition 0.000 description 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 235000015112 vegetable and seed oil Nutrition 0.000 description 12
- 239000008158 vegetable oil Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 10
- 102000004127 Cytokines Human genes 0.000 description 10
- 108090000695 Cytokines Proteins 0.000 description 10
- 241000282898 Sus scrofa Species 0.000 description 10
- 125000004432 carbon atom Chemical group C* 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 238000002386 leaching Methods 0.000 description 9
- 108010065805 Interleukin-12 Proteins 0.000 description 8
- 102000013462 Interleukin-12 Human genes 0.000 description 8
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 8
- 235000021120 animal protein Nutrition 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 210000000822 natural killer cell Anatomy 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 8
- 239000004472 Lysine Substances 0.000 description 7
- 210000002540 macrophage Anatomy 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 108010074328 Interferon-gamma Proteins 0.000 description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 6
- 101000981253 Mus musculus GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Proteins 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 6
- 229960002986 dinoprostone Drugs 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 230000002757 inflammatory effect Effects 0.000 description 6
- 235000018977 lysine Nutrition 0.000 description 6
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 6
- 235000019710 soybean protein Nutrition 0.000 description 6
- 235000019489 Almond oil Nutrition 0.000 description 5
- 244000205479 Bertholletia excelsa Species 0.000 description 5
- 235000012284 Bertholletia excelsa Nutrition 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 235000007516 Chrysanthemum Nutrition 0.000 description 5
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 5
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 5
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 5
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 5
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 210000001744 T-lymphocyte Anatomy 0.000 description 5
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 5
- 239000004473 Threonine Substances 0.000 description 5
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 5
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 5
- 239000008168 almond oil Substances 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 229960005069 calcium Drugs 0.000 description 5
- 239000002158 endotoxin Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000012091 fetal bovine serum Substances 0.000 description 5
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 5
- 230000028993 immune response Effects 0.000 description 5
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 5
- 229960000310 isoleucine Drugs 0.000 description 5
- 229920006008 lipopolysaccharide Polymers 0.000 description 5
- 229930182817 methionine Natural products 0.000 description 5
- 239000010466 nut oil Substances 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000004474 valine Substances 0.000 description 5
- 235000014393 valine Nutrition 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 230000004580 weight loss Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 4
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 4
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 4
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 4
- 229930003779 Vitamin B12 Natural products 0.000 description 4
- 229930003316 Vitamin D Natural products 0.000 description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 239000006143 cell culture medium Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 238000005194 fractionation Methods 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- -1 granular Substances 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 229960003284 iron Drugs 0.000 description 4
- 229930014626 natural product Natural products 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 235000003441 saturated fatty acids Nutrition 0.000 description 4
- 150000004671 saturated fatty acids Chemical class 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000019163 vitamin B12 Nutrition 0.000 description 4
- 239000011715 vitamin B12 Substances 0.000 description 4
- 235000019166 vitamin D Nutrition 0.000 description 4
- 239000011710 vitamin D Substances 0.000 description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 description 4
- 229940046008 vitamin d Drugs 0.000 description 4
- 239000011534 wash buffer Substances 0.000 description 4
- 244000105624 Arachis hypogaea Species 0.000 description 3
- 102000008015 Hemeproteins Human genes 0.000 description 3
- 108010089792 Hemeproteins Proteins 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 102100037850 Interferon gamma Human genes 0.000 description 3
- 102000008070 Interferon-gamma Human genes 0.000 description 3
- 108010050904 Interferons Proteins 0.000 description 3
- 102000014150 Interferons Human genes 0.000 description 3
- 102000015696 Interleukins Human genes 0.000 description 3
- 108010063738 Interleukins Proteins 0.000 description 3
- 241000758791 Juglandaceae Species 0.000 description 3
- 102000004083 Lymphotoxin-alpha Human genes 0.000 description 3
- 108090000542 Lymphotoxin-alpha Proteins 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 230000006051 NK cell activation Effects 0.000 description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 3
- 235000011613 Pinus brutia Nutrition 0.000 description 3
- 241000018646 Pinus brutia Species 0.000 description 3
- 108010064851 Plant Proteins Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000028709 inflammatory response Effects 0.000 description 3
- 229940079322 interferon Drugs 0.000 description 3
- 229960003130 interferon gamma Drugs 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 235000020232 peanut Nutrition 0.000 description 3
- 235000021118 plant-derived protein Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- YIBNHAJFJUQSRA-YNNPMVKQSA-N prostaglandin H2 Chemical compound C1[C@@H]2OO[C@H]1[C@H](/C=C/[C@@H](O)CCCCC)[C@H]2C\C=C/CCCC(O)=O YIBNHAJFJUQSRA-YNNPMVKQSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 210000004988 splenocyte Anatomy 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 235000020238 sunflower seed Nutrition 0.000 description 3
- 241000712461 unidentified influenza virus Species 0.000 description 3
- 235000020234 walnut Nutrition 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 235000019737 Animal fat Nutrition 0.000 description 2
- 241000512259 Ascophyllum nodosum Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241001454694 Clupeiformes Species 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- 102000004889 Interleukin-6 Human genes 0.000 description 2
- 240000000599 Lentinula edodes Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 102100029438 Nitric oxide synthase, inducible Human genes 0.000 description 2
- 101710089543 Nitric oxide synthase, inducible Proteins 0.000 description 2
- 241000233855 Orchidaceae Species 0.000 description 2
- 244000088415 Raphanus sativus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- 102000008233 Toll-Like Receptor 4 Human genes 0.000 description 2
- 108010060804 Toll-Like Receptor 4 Proteins 0.000 description 2
- 240000001260 Tropaeolum majus Species 0.000 description 2
- 235000004424 Tropaeolum majus Nutrition 0.000 description 2
- 235000019513 anchovy Nutrition 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 235000018823 dietary intake Nutrition 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 208000026278 immune system disease Diseases 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000015788 innate immune response Effects 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 210000004989 spleen cell Anatomy 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002993 trophoblast Anatomy 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- 235000003563 vegetarian diet Nutrition 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 238000004260 weight control Methods 0.000 description 2
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010048998 Acute phase reaction Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 101000862089 Clarkia lewisii Glucose-6-phosphate isomerase, cytosolic 1A Proteins 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 101000988802 Homo sapiens Hematopoietic prostaglandin D synthase Proteins 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 102000003996 Interferon-beta Human genes 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 231100000416 LDH assay Toxicity 0.000 description 1
- 102100037611 Lysophospholipase Human genes 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 101001054328 Mus musculus Interferon beta Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- NULAJYZBOLVQPQ-UHFFFAOYSA-N N-(1-naphthyl)ethylenediamine Chemical compound C1=CC=C2C(NCCN)=CC=CC2=C1 NULAJYZBOLVQPQ-UHFFFAOYSA-N 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000587753 Nymphaea tetragona Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108010058864 Phospholipases A2 Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 102100030484 Prostaglandin E synthase 2 Human genes 0.000 description 1
- 108050003514 Prostaglandin E synthase 2 Proteins 0.000 description 1
- 102100038277 Prostaglandin G/H synthase 1 Human genes 0.000 description 1
- 108050003243 Prostaglandin G/H synthase 1 Proteins 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000245165 Rhododendron ponticum Species 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 210000000447 Th1 cell Anatomy 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000004658 acute-phase response Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000008267 autocrine signaling Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910001576 calcium mineral Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 1
- 229930002863 chlorophyll d Natural products 0.000 description 1
- QXWRYZIMSXOOPY-SKHCYZARSA-M chlorophyll d Chemical compound C1([C@H](C2=O)C(=O)OC)=C(N3[Mg]N45)C2=C(C)\C3=C\C(=N2)C(CC)=C(C)\C2=C\C4=C(C=O)C(C)=C5\C=C/2[C@@H](C)[C@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C1=N\2 QXWRYZIMSXOOPY-SKHCYZARSA-M 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000015223 cooked beef Nutrition 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000013931 endocrine signaling Effects 0.000 description 1
- 239000012645 endogenous antigen Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000001056 green pigment Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 108010045648 interferon omega 1 Proteins 0.000 description 1
- 229960001388 interferon-beta Drugs 0.000 description 1
- 229940117681 interleukin-12 Drugs 0.000 description 1
- 230000019734 interleukin-12 production Effects 0.000 description 1
- 229940100601 interleukin-6 Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910001608 iron mineral Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000002843 lactate dehydrogenase assay Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- DGNIJJSSARBJSH-NLJAFYFLSA-L magnesium (E)-3-[(3R)-16-ethenyl-11-ethyl-3-methoxycarbonyl-12,17,21,26-tetramethyl-4-oxo-7,24-diaza-23,25-diazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1(22),2(6),5(26),7,9,11,13,15(24),16,18,20-undecaen-22-yl]prop-2-enoic acid Chemical compound [Mg++].CCc1c(C)c2cc3nc(cc4[n-]c(c(\C=C\C(O)=O)c4C)c4[C@@H](C(=O)OC)C(=O)c5c(C)c(cc1[n-]2)nc45)c(C)c3C=C DGNIJJSSARBJSH-NLJAFYFLSA-L 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000021274 meat intake Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 101800000857 p40 protein Proteins 0.000 description 1
- 230000014306 paracrine signaling Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- BHMBVRSPMRCCGG-OUTUXVNYSA-N prostaglandin D2 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O BHMBVRSPMRCCGG-OUTUXVNYSA-N 0.000 description 1
- SGUKUZOVHSFKPH-YNNPMVKQSA-N prostaglandin G2 Chemical compound C1[C@@H]2OO[C@H]1[C@H](/C=C/[C@@H](OO)CCCCC)[C@H]2C\C=C/CCCC(O)=O SGUKUZOVHSFKPH-YNNPMVKQSA-N 0.000 description 1
- KAQKFAOMNZTLHT-OZUDYXHBSA-N prostaglandin I2 Chemical compound O1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-OZUDYXHBSA-N 0.000 description 1
- BHMBVRSPMRCCGG-UHFFFAOYSA-N prostaglandine D2 Natural products CCCCCC(O)C=CC1C(CC=CCCCC(O)=O)C(O)CC1=O BHMBVRSPMRCCGG-UHFFFAOYSA-N 0.000 description 1
- 229940127293 prostanoid Drugs 0.000 description 1
- 150000003814 prostanoids Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 102000034285 signal transducing proteins Human genes 0.000 description 1
- 108091006024 signal transducing proteins Proteins 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000006433 tumor necrosis factor production Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
- A23L13/42—Additives other than enzymes or microorganisms in meat products or meat meals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
- A23L13/42—Additives other than enzymes or microorganisms in meat products or meat meals
- A23L13/424—Addition of non-meat animal protein material, e.g. blood, egg, dairy products, fish; Proteins from microorganisms, yeasts or fungi
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
- A23L13/42—Additives other than enzymes or microorganisms in meat products or meat meals
- A23L13/428—Addition of flavours, spices, colours, amino acids or their salts, peptides, vitamins, yeast extract or autolysate, nucleic acid or derivatives, organic acidifying agents or their salts or acidogens, sweeteners, e.g. sugars or sugar alcohols; Addition of alcohol-containing products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
- A23L13/42—Additives other than enzymes or microorganisms in meat products or meat meals
- A23L13/432—Addition of inorganic compounds, e.g. minerals; oligo-elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Definitions
- the present invention relates to plant meat. More specifically, it relates to plant meat that can reproduce the texture and taste of animal proteins, including proteins and essential amino acids isolated from soybeans, rice and wheat plants, and exhibiting antibacterial, antiviral and anti-inflammatory activities.
- the composition of animal meat differs depending on the type of meat, and even the same meat differs according to age and body parts, and the characteristics of meat are also different.
- Edible muscle is 75% water, 25% solid, protein, and the rest contains lipids, minerals, vitamins, and a small amount of carbohydrates.
- fat contains 5 to 40%, and the content varies depending on the type and part of the meat, but it is mainly an accumulating neutral fat, and the type of fatty acid is mainly saturated fatty acids such as palmitic acid, stearic acid, and oleic acid. and the content of highly unsaturated fatty acids is low. Therefore, some people avoid eating meat because it can become a causative agent of adult diseases such as obesity, fatty liver, and arteriosclerosis that can occur due to excessive intake of triglycerides and saturated fatty acids. to do
- plant meat has similar nutrition and shape to animal meat, it has a disadvantage in that it shows a lot of difference in texture from animal meat, which has a large amount of actual juice, due to low succulence after cooking.
- Plant meat (meat analogue or meat alternative) can be divided into powder, granular, solid, paste, etc. according to its properties. spun proteins).
- Plant meat prepared with such plant protein has a structure similar to meat, absorbs moisture easily, and can consume protein without cholesterol, so it has the advantage of excellent nutritional value.
- vegetable meat includes wheat and soybean meat, which are made with proteins extracted from wheat and soybeans, respectively, so that you can enjoy the taste of meat while eliminating various disadvantages of animal meat.
- Soybean is a plant-based soybean that has a texture and taste similar to that of meat using soybean protein and gluten, a wheat protein, using tissue protein that is organized into protein.
- soybean protein contains abundant essential amino acids, has cholesterol lowering effect, anticancer effect, and prevents osteoporosis, and is used as an alternative food for animal protein because it is cheaper than animal protein.
- Plant-based meat does not contain animal fat and does not contain cholesterol or saturated fatty acids, so it helps to prevent cardiovascular diseases and lifestyle-related diseases.
- the digestion time of plant-based meat is shorter than that of meat, so there is less burden on the stomach and intestines.
- soybean protein and wheat protein have received considerable attention as substitutes for expensive animal protein, but they cannot completely replace the texture or physical properties of animal protein.
- cytokines and active nitrogen species attach to various organs and body organs and cause tissue damage and further exacerbate genetic mutations, nerve damage, edema, and itchiness.
- cytokines are immune substances, and when overexpressed, they cause an immune overreaction that attacks normal cells, weakening the body's immunity, and causing inflammation and bleeding in tissues, and high fever of 40°C or higher.
- the vegetable meat prepared from vegetable protein exhibits an anti-inflammatory effect, it can easily absorb moisture and consume protein without cholesterol, and at the same time exhibit an anti-inflammatory effect, etc., can have the advantage of excellent nutritional value.
- Patent Document 1 KR 10-2014-0143315 A1
- An object of the present invention is a vegetable meat that exhibits antibacterial, antiviral and anti-inflammatory activity prepared by using a protein isolated from soybean or wheat. It is to provide improved plant meat and a method for preparing the same.
- Another object of the present invention is to provide a vegetable meat that can provide the same level of texture and taste as meat, can provide nutrients including essential amino acids when ingested in a balanced way, and can control body weight.
- vegetable meat includes vegetable protein consisting of soy protein, gluten, and a mixture thereof, and heme-containing protein isolated from cattle, pig or chicken, chlorophyll, and a mixture thereof Including those selected from the group consisting of, it may exhibit antibacterial, antiviral and anti-inflammatory activity.
- the vegetable meat may further include wheat flour.
- the heme-containing protein can be isolated from beef, pork, chicken, beef, pork skin and chicken skin.
- the vegetable meat may further include beets and coconut oil.
- the vegetable meat contains essential amino acids of histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan and valine; Calcium and iron may be further included.
- the plant meat exhibits anti-inflammatory activity through inhibition of nitric oxide (NO) production.
- NO nitric oxide
- a food composition according to another embodiment of the present invention is prepared by including the vegetable meat.
- anti-inflammatory and “anti-inflammatory” are meant to include alleviation (relief of symptoms) of inflammatory diseases as defined below, and suppression or delay of the onset of such diseases.
- immune disease refers to a disease caused by an excessive reaction of the immune system in the human body, and typically includes allergic diseases. However, since the inflammatory response is ultimately caused by the reaction of the immune system in the body, inflammatory disease and immune disease can be used as terms referring to similar ranges in a broad sense, and are not used as distinctly distinct terms in the present specification. , will be mixed.
- Plant meat according to an embodiment of the present invention includes vegetable protein consisting of soy protein, gluten, and a mixture thereof, and is selected from the group consisting of heme-containing protein isolated from cattle, pig or chicken, chlorophyll, and mixtures thereof. Including, antibacterial, antiviral and anti-inflammatory activity.
- a protein selected from the group consisting of heme-containing protein, chlorophyll, and mixtures thereof isolated from cattle, pigs or chickens.
- Plant-based meat does not contain animal fat and does not contain cholesterol or saturated fatty acids, which helps to prevent cardiovascular diseases and lifestyle-related diseases.
- Plant meat made with plant protein has a structure similar to that of meat, absorbs moisture easily and can consume protein without cholesterol, providing excellent nutrients and preventing diseases caused by eating large amounts of meat. .
- soybean meat The vegetable meat is widely known as soybean meat, and has a texture and taste similar to meat, and is called "meat”.
- the main ingredients and manufacturing methods of general vegetable meat are as follows.
- Soybeans are boiled and ground to obtain soy protein, and nuts are mixed and ground together to improve texture and taste. Thereafter, it is mixed with flour to make a dough, which is then frozen or heated to make vegetable meat.
- the main ingredients of plant meat are soybean protein and gluten separated from wheat, which can be kneaded and heated to provide a texture similar to meat, but there is a problem in that it cannot provide the unique taste and flavor of meat.
- heme-containing proteins isolated from cattle, pigs or chickens, chlorophyll, and mixtures thereof may be included.
- pig blood, cow blood, or chicken blood generated during the slaughter process is generally discarded or provided as slaughter.
- cow blood is coagulated, boiled and used as seonjitguk, or when making sundae.
- Pig blood or cow blood is not used in conventional food, but only some foods such as seonjitguk or sundae.
- Seonji in the case of Seonji, it can play a role in providing a number of nutrients contained in the blood of cattle when ingested, but when provided as food, it does not correspond to a food with high preference due to its unique texture and taste.
- such pig blood, cow blood or chicken blood contains heme protein, and when it is separated and mixed with vegetable protein, it is possible to provide a unique smell and taste of pork, beef or chicken.
- the pork, beef or chicken is an important factor that can increase the preference for people who eat it with texture, but it is not possible to provide such a unique flavor when using only vegetable protein. made it impossible to provide
- beets are also used as a natural dye to give the meat a reddish color.
- plant proteins cannot represent the same color as meat, so to represent a similar color, beets were artificially used to reproduce a color similar to meat.
- the method of isolating heme-containing proteins from cattle, pigs or chickens is a method of separating hemoglobin from red blood cells in blood and adding carboxymethy cellulose (CMC) to precipitate heme with CMC complex, low-grade
- CMC carboxymethy cellulose
- a method of using a dehydrating agent such as alcohol, an imidazole derivative, or a method of adding an amino acid of lysine or arginine may be used.
- the heme-containing protein In the method of separating the heme-containing protein, it may be separated from the blood of cattle, pigs or chickens, or the heme protein contained in beef, pork, or chicken may be separated.
- the separation of the heme-containing protein is not limited to the method exemplified above, and any of them can be used without limitation, and it is possible to separate from the blood or meat of cattle, pigs, or chickens, and is not limited to the above examples.
- chlorophyll may be used in addition to the heme-containing protein isolated from cattle, pigs or chickens.
- the chlorophyll is currently marketed as chlorophyll and can be easily purchased.
- the chlorophyll is a green pigment contained in plants, and is a pigment that acts as an antenna for absorbing light energy as a key molecule in photosynthesis.
- chlorophyll There are several types of chlorophyll, such as chlorophyll a, chlorophyll b, chlorophyll c, chlorophyll d, chlorophyll e, theriochlorophyll a and theriochlorophyll b.
- chlorophyll When chlorophyll is included, the taste of vegetable meat can be improved by the component contained in chlorophyll.
- the vegetable meat of the present invention contains the heme-containing protein, it is possible to provide a taste and flavor that was not sufficient with vegetable meat alone.
- a vegetable meat dough composition is prepared by mixing chlorophyll and a mixture thereof, and grinding it using a blender, followed by mixing with flour to increase viscosity.
- the nuts are included for replenishment of essential amino acids, and enable the provision of balanced nutrients along with improving the texture of plant meat.
- the dough is stirred several times to improve its texture, and then heated to make vegetable meat. A more specific manufacturing method will be described later.
- the vegetable meat may further include beets and coconut oil. As described above, beets are included to provide the color of vegetable meat similar to meat.
- the vegetable meat of the present invention additionally contains coconut oil, so that soybeans, nuts, pig blood or cow blood and flour are mixed and used to enable even mixing between the components, and when provided as vegetable meat , it is provided in the same form as meat juice due to the mixing action between the constituents, thereby further increasing the preference.
- it may further include a complex vegetable oil in which almond oil and Brazil nut oil are mixed with the coconut oil.
- a water lily extract and a water lily extract may be further included.
- the water lily (Nymphaea tetragona Georgi) is a perennial aquatic plant that grows in ponds or swamps. The leaves are from the root, and the petiole is long, ovate, round, and the edge is flat. The flowers are white or red and bloom for 3 days from June to July and then close. The fruit is egg-shaped and wrapped in a calyx, and the seeds have fleshy species.
- the rhododendron (Tropaeolum majus L.) is a vine-like annual plant that is cultivated and reaches 1.5 m in length and is fleshy. The leaves are alternate, and at the tip of a long petiole, the shield-like leaves have 9 veins spread out in all directions and have some hairs. In June, a long peduncle emerges from the leaf axil, and one flower hangs at the end. There is one seed and it does not open even after maturity.
- the water lily extract and the orchid extract are additionally included in the production of vegetable meat, enabling it to be provided with a soft texture and, at the same time, removing the unique fishy taste and smell caused by the use of heme-containing protein, making it a highly preferred vegetable meat. make it possible to provide
- the preparation of the water lily extract and the water lily extract includes the steps of pulverizing a natural product; leaching the pulverized product using an organic solvent; drying the sample after leaching; re-leaching the dried sample using a solvent; drying the sample after leaching; leaching with water; And including the step of leaching, it is possible to obtain a natural extract.
- the method may further include performing fractionation of the natural extract extracted using the organic solvent using an organic solvent.
- the method for preparing the extract may be a conventional extraction method in the art, such as an ultrasonic extraction method, a leaching method, and a reflux extraction method. Specifically, it may be an extract obtained by extracting a natural product from which foreign substances have been removed by washing and drying with water, an alcohol having 1 to 6 carbon atoms, or a mixed solvent thereof, or may be an extract extracted by sequentially applying the solvents to the sample.
- the reflux extraction method is based on 100 mL of alcohol having 1 to 6 carbon atoms, 10 to 30 g of a pulverized product of a natural product, reflux time of 1 to 3 hours, and 50 to 100% alcohol having 1 to 6 carbon atoms. More specifically, based on 100 mL of alcohol having 1 to 6 carbon atoms, 10 to 20 g of the pulverized product of the natural product, 1 to 2 hours reflux, and 70 to 90% alcohol having 1 to 4 carbon atoms.
- the leaching method is 15 to 30° C. for 24 to 72 hours and 50 to 100% alcohol having 1 to 6 carbon atoms. More specifically, 20 to 25° C. for 30 to 54 hours and 70 to 80% of an alcohol having 1 to 6 carbon atoms.
- the ultrasonic extraction method is 30 to 50° C., for 0.5 to 2.5 hours, and 50 to 100% of alcohol having 1 to 6 carbon atoms. Specifically, 40 to 50° C., for 1 to 2.5 hours, and 70 to 80% of an alcohol having 1 to 6 carbon atoms.
- the extraction solvent may be used in an amount of 2 to 50 times, more specifically, 2 to 20 times, based on the weight of the sample.
- the sample may be left for 1 to 72 hours for leaching in the extraction solvent, and more specifically, for 24 to 48 hours.
- the extract may be fractionated by sequentially applying a fresh fractionation solvent.
- the fractionation solvent used for fractionation is any one or more selected from the group consisting of water, hexane, butanol, ethyl acetic acid, ethyl acetate, methylene chloride and mixtures thereof, preferably ethyl acetate or methylene chloride.
- a method such as concentration or freeze-drying may be additionally used.
- the vegetable meat of the present invention contains essential amino acids of histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan and valine; It may further include vitamins, calcium and iron.
- the essential amino acid refers to an amino acid that cannot be synthesized in the body as a basic structural unit of a protein. That is, since it is an amino acid that cannot be synthesized in the body, it must be ingested only through food, or an amino acid that must be supplied through food because its amount is too small to achieve physiological functions even though it is synthesized in the body.
- plant-based meat was developed as a substitute for meat for those who consume plant-based meat or for those who refuse to eat meat, such as vegetarians, plant-based meat itself does not contain the essential amino acids contained in meat. It did not contain enough, so it was impossible to supply essential amino acids by eating plant-based meat alone.
- heme-containing protein and/or chlorophyll are included in plant meat to enable provision of a product with increased preference unlike conventional plant meat, and even if heme-containing protein and/or chlorophyll are included, essential By additionally including amino acids, vitamins, calcium and iron, even if only the plant meat of the present invention is consumed, it is possible to supply sufficient nutrients to the body.
- the vegetable meat of the present invention including soy protein, gluten, and vegetable protein consisting of a mixture thereof, enables the provision of protein, and enables the supply of iron from heme-containing protein and/or chlorophyll to a certain extent.
- the vegetable meat of the present invention including soy protein, gluten, and vegetable protein consisting of a mixture thereof, enables the provision of protein, and enables the supply of iron from heme-containing protein and/or chlorophyll to a certain extent.
- the supply of iron is not sufficient.
- the essential amino acids, vitamins, calcium and iron are additionally included to enable the supply of sufficient nutrients due to ingestion of plant meat.
- the vitamin is vitamin B12 and vitamin D, which cannot be consumed in a vegetarian diet, and is intended to solve the problem of unbalanced nutritional intake.
- a method for producing vegetable meat according to another embodiment of the present invention comprises the steps of 1) boiling soybeans in boiling water for 10 to 20 minutes to remove the fishy smell of soybeans; 2) preparing a soybean mixture by mixing the soybeans from which the fishy smell has been removed with nuts selected from the group consisting of pine nuts, walnuts, peanuts, sunflower seeds, and mixtures thereof, and pulverizing them using a blender; 3) adding flour to the soybean mixture and kneading; and 4) after the kneading step, a step of heating, wherein step 2) is to add and mix heme-containing protein, chlorophyll, essential amino acids, vitamins, calcium and iron isolated from cattle, pigs or chickens.
- step 1) is a step of boiling soybeans to remove the fishy smell characteristic of soybeans.
- kelp, radish, dried anchovies and dried shiitake mushrooms are put in water and boiled. If the soybeans are put in boiling water and heated for 10 to 20 minutes to cook the soybeans, the unique fishy taste of the soybeans can be removed.
- soybeans from which the fishy taste has been removed are mixed with heme-containing protein and/or chlorophyll, beets, mixed vegetable oil, water lily extract and hanryeon extract isolated from nuts, cows, pigs or chickens, and then pulverized using a blender At the same time, make sure to mix evenly.
- Essential amino acids, vitamins, calcium and iron are further mixed in the pulverized and mixed mixture. Specifically, by including histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine, vitamin B12, vitamin D, calcium and iron, nutrients lacking in plant meat can be supplemented.
- soybeans based on 100 parts by weight of soybeans, 30 to 50 parts by weight of nuts, 20 to 30 parts by weight of heme-containing protein and/or chlorophyll isolated from cattle, pigs or chickens, 5 to 10 parts by weight of beets, 10 to 20 parts by weight of complex vegetable oil parts by weight, 1 to 5 parts by weight of water lily extract, 1 to 5 parts by weight of nasturtium extract, 0.01 to 0.1 parts by weight of histidine, 0.01 to 0.1 parts by weight of isoleucine, 0.01 to 0.1 parts by weight of leucine, 0.01 to 0.1 parts by weight of lysine; Methionine 0.01 to 0.1 parts by weight, phenylalanine 0.01 to 0.1 parts by weight, threonine 0.01 to 0.1 parts by weight, tryptophan 0.01 to 0.1 parts by weight, valine 0.01 to 0.1 parts by weight, vitamin B12 0.01 to 0.1 parts by weight, vitamin D 0.01 to 0.1 parts by weight ,
- the weight loss effect is excellent during long-term ingestion of vegetable meat, and weight loss with high preference Enables the provision of vegetable meat for use.
- the complex vegetable oil is included in an amount of 18 to 20 parts by weight, it is possible to provide vegetable meat with high preference and at the same time to provide vegetable meat which can exhibit an excellent effect on weight gain.
- the content range of the complex vegetable oil can be varied according to the use of the food provided.
- the complex vegetable oil is a mixture of coconut oil, almond oil and Brazil nut oil in a weight ratio of 1:1:1.
- step 2 After preparing the soybean mixture in step 2), flour is added to prepare a dough.
- step 3 5 to 10 parts by weight of a soybean mixture and 100 to 120 parts by weight of water are mixed with respect to 100 parts by weight of wheat flour and mixed, and prepared as a dough, to prepare a vegetable meat dough composition.
- the dough composition may be molded into a predetermined shape and heated to provide vegetable meat.
- the heating step is a step of cooking the vegetable meat dough composition molded to a thickness of 5 to 10 cm by heating it using heated steam for 30 to 60 minutes.
- the vegetable meat dough composition can be cooked, but when heated for 30 to 60 minutes using heated steam, rather than when heat is directly provided, it becomes cooked while supplying moisture inside, and when consumed
- the juice is provided in the same form as the juice of meat, so that it can provide a texture and taste similar to that of meat as well as a soft texture.
- the plant meat exhibits anti-inflammatory activity through inhibition of nitric oxide (NO) production.
- NO nitric oxide
- the vegetable meat may exhibit an anti-inflammatory effect by inhibiting the production of nitric oxide (NO).
- NO nitric oxide
- lipopolysaccharide is an endotoxin derived from the cell wall of Gram-negative bacteria and activates the transcription factor NF- ⁇ B by binding to toll-like receptor 4 (TLR4), iNOS and COX-2 It induces the expression of NO, inflammatory cytokines, and various inflammatory regulators such as PGE2.
- the plant meat of the present invention inhibits the production of NO, inflammatory (IL-1 ⁇ , IL-6, TNF- ⁇ ), PGE2, COX-2 and iNOS in a concentration-dependent manner, and can be used as an anti-inflammatory agent.
- the PGE2 is one of the inflammatory mediators and is synthesized by the enzymatic action of phospholipase A2. It starts with the production of arachidonic acid from membrane phospholipids.
- the arachidonic acid becomes prostaglandin G2 by enzymatic action and again becomes prostaglandin H2, an unstable metabolite.
- COX cyclooxygenase
- PGH2 produced by COX is an unstable intermediate metabolite and is metabolized into PGE2, PGD2, PGI2, PGF2, thromboxane A2 (TXA2), etc. by various prostanoid synthases depending on the type of cell or stimulation.
- PGES PGE synthase
- cPGES cytosolic PGES
- mPGES-1 microsomal PGES-1
- mPGES-2 cytosolic PGES
- mPGES-1 expression is increased by inflammatory stimuli such as lipopolysaccharid (LPS), inflammatory cytokines such as IL-1 ⁇ and TNF- ⁇ , and nitric oxide (NO), and is functionally closely related to COX-2. It is closely linked to the production of PGE2.
- LPS lipopolysaccharid
- NO inflammatory cytokines
- COX-2 nitric oxide
- the plant meat of the present invention exhibits anti-inflammatory activity through inhibition of nitric oxide (NO) production.
- NO nitric oxide
- NK cells natural killer cells
- NK cells are one of the innate immune cells and directly interact with various macrophages and T cells or generate cytokines for an immune response. It is involved in regulation and is known to play an important role in autoimmune diseases and the like.
- the cytokine is a protein immunomodulator secreted from immune cells, and binds to a specific receptor during autocrine signaling, paracrine signaling, and endocrine signaling to give immunity. involved in the reaction.
- interleukin-1,-6,-12 interleukin-1,-6,-12
- IFN- ⁇ interferon gamma
- TNF tumor necrosis factor
- Interleukin is secreted from leukocytes and is involved in immune system regulation, and more than 30 types are currently known. Interleukin is a substance that plays an important role in the defense of the human body by regulating the immune response by acting on various stages of the immune response.
- IL-12 is a cytokine composed of p35 and p40 proteins. It has a very important immunological function that connects innate immunity and acquired immunity, and various effector cells involved in the removal of endogenous antigens, i.e., macrophages ), induces activation of NK cells and T-cells.
- NK cells and T-cells activated by IL-12 stimulation have properties as major factors mediating the initial innate immune response by stimulating the production of IFN- ⁇ . It is also the most important cellular immune mediator because it induces the immune machinery of T-cells to become predominantly Th-1 propensity.
- Interferon functions to prevent proliferation of viruses or control cell proliferation, and also plays an important function in the immune system.
- Interferon- ⁇ is mainly secreted by macrophages and interferon- ⁇ is mainly secreted by fibroblasts.
- Interferon- ⁇ is secreted by Th1 cells and NK cells, and interferon- ⁇ is mainly secreted by trophoblasts or Trophoblasts.
- interferon- ⁇ IFN- ⁇
- IFN- ⁇ interferon- ⁇
- IFN- ⁇ interferon- ⁇
- T lymphocytes and macrogranulocytes is a substance that induces the killing of preyed microorganisms or antigens. In addition, it has various immunomodulatory actions and activates macrophages.
- TNF tumor necrosis factor
- TNF- ⁇ tumor necrosis factor- ⁇
- TNF- ⁇ tumor necrosis factor- ⁇
- TNF- ⁇ tumor necrosis factor- ⁇
- the plant meat of the present invention increases the production of cytokines TNF- ⁇ and IL-12 that activate the immune response.
- a food composition according to another embodiment of the present invention is prepared by including the vegetable meat.
- the food composition of the present invention may be prepared in any one formulation selected from the group consisting of, for example, tablets, granules, powders, capsules, liquid solutions and pills.
- the food composition of the present invention is not particularly limited in its form, and for example, may be prepared in the form of liquid food, enteral nutrition food, health food, infant food, etc. in addition to the usual form.
- processed oils and fats such as rice, various seasonings, combined oils and fats, margarine, shortening, mayonnaise, and dressings are possible.
- any form commonly used in the art such as a solid form, a semi-solid form, a gel form, a liquid form, a powder form, is available as a form.
- the food composition of the present invention can be commercialized in the form of confectionery, processed food, combination fats and oils, dairy products, beverages, vitamin complexes, health functional foods, and the like.
- the food composition of the present invention contains various nutrients, vitamins, electrolytes, flavoring agents, coloring agents and thickening agents, pectic acid, alginic acid, organic acids, protective colloidal thickeners, pH regulators, stabilizers, and preservatives. , glycerin, alcohol, a carbonation agent used in carbonated beverages, and the like, and these components may be used independently or in combination.
- the vegetable meat and its production method of the present invention is a vegetable meat prepared using a protein isolated from soybean or wheat, and the protein is mixed with heme protein and/or chlorophyll isolated from cattle, pig or chicken, You can provide plant-based meat with improved
- FIG. 1 is a flowchart of a method for producing vegetable meat according to an embodiment of the present invention.
- Figure 2 is a graph showing the inhibition of the production of nitric oxide (NO) of vegetable meat according to an embodiment of the present invention.
- FIG. 3 is a graph showing an increase in the production of TNF- ⁇ in vegetable meat according to an embodiment of the present invention.
- FIG. 4 is a graph showing an increase in the production of interleukin-12 in plant meat according to an embodiment of the present invention.
- FIG. 5 is a graph showing the NK cell activation effect of plant meat in an embodiment of the present invention.
- the present invention relates to plant meat. More specifically, it relates to plant meat that can reproduce the texture and taste of animal proteins, including proteins and essential amino acids isolated from soybeans, rice and wheat plants, and exhibiting antibacterial, antiviral and anti-inflammatory activities.
- Orchid extract was also prepared in the same manner as water lily extract.
- Kelp, radish, dried anchovies and dried shiitake mushrooms were put in water and heated. Soybeans were put in the boiling water and cooked to remove the fishy taste peculiar to soybeans.
- Soybeans from which the fishy taste was removed were mixed with pine nuts, walnuts, peanuts, sunflower seeds, heme-containing protein, beets, coconut oil, almond oil and Brazil nut oil, and then put in a blender and pulverized.
- a vegetable meat dough composition was prepared by mixing and mixing wheat flour and water with the soybean mixture.
- the vegetable meat dough composition was prepared by mixing 10 parts by weight of a soybean mixture and 100 parts by weight of water with respect to 100 parts by weight of wheat flour.
- the vegetable meat dough composition was molded to a thickness of 5 to 10 cm, put in a steamer, and heated for 60 minutes to prepare vegetable meat.
- the heme-containing protein was prepared by treating bovine blood with L-arginine and L-lysine in a ratio of 1:5, followed by stirring and centrifugation.
- heme-Fe was purchased from the market and used to replace the heme-containing protein and iron.
- the content range of the soybean mixture is shown in Table 1 below.
- Chlorophyll is added instead of heme-containing protein, and the soybean mixture prepared in the same content range as the PM3 mixture is PM10,
- a sensory experiment was conducted on 15 adult male and female subjects. Evaluation of texture, taste, and overall preference was requested, and evaluation was requested with a score of 1 to 10 points. A higher score means better evaluation.
- cooked beef was first provided, and a relative comparison with the provided beef was requested. The higher the relative evaluation score, the better.
- Influenza virus was analyzed by infecting the mouse macrophage, Raw 264.7 cells (8 ⁇ 10 5 cells/well).
- the PM1 to PM11 prepared above were treated in DMEM with 1% FBS, respectively.
- the negative control group was treated only with DMEM supplemented with 1% FBS, and the positive control group was treated with mouse IFN- ⁇ (500 units/ml).
- PR8-GFP MOI: 1.0 was inoculated, respectively.
- the inoculum was removed, washed 3 times with PBS, and after 12 and 24 hours, the degree of virus infection was checked.
- the antiviral activity analysis results for the influenza virus are shown in Table 4 below, and the degree of virus infection is expressed as an index.
- the effect of PM1 to PM11 was compared by setting the negative control as 2 and the positive control as index 5. The higher the following indices, the better.
- the mouse macrophage line RAW 264.7 was dispensed in a 6 well plate and cultured for 24 hours at 37°C, 5% CO2 conditions, then treated with PM1 to PM11 and LPS ( 100 ng/ml) after culturing for 24 hours, the concentration of NO 2- present in the cell culture medium was measured.
- TNF- ⁇ and IL-12 In order to examine the immune function improvement effect of the PM1 to PM11, the production ability of TNF- ⁇ and IL-12 was measured.
- the secretion amount of TNF- ⁇ and IL-12 in the cell culture was measured using an ELISA kit (BD Bioscience, San Diego, CA, USA), and the capture antibody (anti-mouse TNF- ⁇ and IL-12) was placed in a 96-well plate. ) was dispensed and coated overnight at 4 °C.
- washing buffer PBS containing 0.05% Tween-20
- PBS phosphate-buffered saline
- FBS phosphate-buffered saline
- 100 uL of the supernatant of the same cell culture medium used for measuring nitric oxide (NO) was dispensed and reacted at room temperature for 2 hours, followed by washing with washing buffer.
- Each diluted biotinylated anti-mouse TNF- ⁇ and interleukin-6 detection antibody and streptavidin-horseradish peroxidase conjugate solution were added and reacted at room temperature for 1 hour.
- TMB tetramethylbenzidine
- plant meat of the present invention can play an important role in the immune response by differentiating B lymphocytes by increasing the production amount of terleukin-6.
- Splenocytes obtained from mice and YAC-1 cells known as NK-sensitive cells were prepared and used for the experiment.
- the spleen was removed from the mouse, put in HBSS, and disrupted using the forested end of a slide glass, and then passed through a 40 ⁇ m nylon cell strainer (BD Biosciences) to separate the cells.
- red blood cells were removed by adding red blood cell lysis (RBC lysis buffer, sigma), and the obtained splenocytes were cultured in a culture medium (RPMI 1640 containing 10% fetal bovine serum (FBS), 100 U/ ml penicillin, and 100 ⁇ g/ml streptomycin) were used in the experiment.
- a culture medium RPMI 1640 containing 10% fetal bovine serum (FBS), 100 U/ ml penicillin, and 100 ⁇ g/ml streptomycin
- NK cells The cytotoxicity of NK cells was confirmed using a method (LDH cytotoxic assay) for measuring lactate dehydrogenase released from YAC-1 cells destroyed by NK cells attacking YAC-1 cells.
- LDH cytotoxic assay a method for measuring lactate dehydrogenase released from YAC-1 cells destroyed by NK cells attacking YAC-1 cells.
- After the cells were added cultured at 37°C and 5% CO2 for 4 hours, centrifuged, and 100 ⁇ l of the LDH-free supernatant was collected and transferred to a 96-well plate.
- LDH cytotoxic assay was performed using LDH assay kit (BioVision). 100 ⁇ l of LDH working solution was added to the cell culture medium and reacted for 30 minutes in a dark place at room temperature (15-25° C.), and absorbance was measured at 495 nm.
- NK cell activity (%) was calculated according to the following formula, and is shown in FIG. 5 .
- Cytotoxicity (%) ⁇ (test sample) - (low control) ⁇ / ⁇ (high control) - (low control) ⁇ x 100
- the present invention relates to plant meat. More specifically, it relates to plant meat that can reproduce the texture and taste of animal proteins, including proteins and essential amino acids isolated from soybeans, rice and wheat plants, and exhibiting antibacterial, antiviral and anti-inflammatory activities.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
La présente invention concerne un analogue de viande présentant une activité antibactérienne, anti-virale et une activité anti-inflammatoire et peut fournir un analogue de viande, préparé à l'aide de protéines isolées à partir de soja ou de blé, ayant une sapidité améliorée par mélange de sang de bovin, de porc ou de poulet ou d'hémoglobine isolé du sang avec les protéines. De plus, l'analogue de viande peut fournir le même niveau de texture et de goût que de la viande et peut être utilisé comme aliment diététique qui fournit des acides aminés essentiels.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2020-0054557 | 2020-05-07 | ||
KR1020200054557A KR102263365B1 (ko) | 2019-06-17 | 2020-05-07 | 식물성 고기 |
KR10-2020-0068531 | 2020-06-05 | ||
KR1020200068531A KR102241883B1 (ko) | 2020-06-05 | 2020-06-05 | 항균, 항바이러스, 항염 및 면역 기능 개선용 식물성 고기 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021225212A1 true WO2021225212A1 (fr) | 2021-11-11 |
Family
ID=75718643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2020/007791 WO2021225212A1 (fr) | 2020-05-07 | 2020-06-16 | Analogue de viande |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102241883B1 (fr) |
WO (1) | WO2021225212A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113017096A (zh) * | 2021-04-30 | 2021-06-25 | 云南爱尔康生物技术有限公司 | 一种含虾青素的植物肉及其制作方法 |
WO2023182330A1 (fr) * | 2022-03-23 | 2023-09-28 | 株式会社ニチレイフーズ | Aliment transformé de substitution de viande, son procédé de production, procédé d'amélioration de la texture de celui-ci, et améliorant de texture pour aliment traité de substitution de viande |
WO2023201048A3 (fr) * | 2022-04-14 | 2023-11-23 | Omeat Inc. | Systèmes et procédés de préparation de viande cultivée et de succédanés de viande à partir de protéines végétales |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080114072A (ko) * | 2007-06-26 | 2008-12-31 | 전북대학교산학협력단 | 조직콩단백질을 이용한 콩소시지 제조방법 |
KR20150110214A (ko) * | 2014-03-24 | 2015-10-02 | 엔자임빌리지 주식회사 | 허브식물 발효추출액을 함유하는 육류대용식 및 그 제조방법 |
KR20160140790A (ko) * | 2014-03-31 | 2016-12-07 | 임파서블 푸즈 인크. | 분쇄 고기 모조물 |
KR102070385B1 (ko) * | 2019-11-22 | 2020-01-28 | 노은정 | 진세노사이드 및 철분이 보강된 식물성 대체육 첨가물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101296186B1 (ko) * | 2011-07-27 | 2013-08-13 | 송현승 | 식물성 고기의 조성물 및 그의 제조방법 |
KR20140143315A (ko) | 2013-06-05 | 2014-12-16 | 중앙대학교 산학협력단 | 혼합 단백분해효소 처리된 콩단백을 포함하는 식물성 고기의 제조방법 및 이를 이용한 콩불고기 |
-
2020
- 2020-06-05 KR KR1020200068531A patent/KR102241883B1/ko active IP Right Grant
- 2020-06-16 WO PCT/KR2020/007791 patent/WO2021225212A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080114072A (ko) * | 2007-06-26 | 2008-12-31 | 전북대학교산학협력단 | 조직콩단백질을 이용한 콩소시지 제조방법 |
KR20150110214A (ko) * | 2014-03-24 | 2015-10-02 | 엔자임빌리지 주식회사 | 허브식물 발효추출액을 함유하는 육류대용식 및 그 제조방법 |
KR20160140790A (ko) * | 2014-03-31 | 2016-12-07 | 임파서블 푸즈 인크. | 분쇄 고기 모조물 |
KR102070385B1 (ko) * | 2019-11-22 | 2020-01-28 | 노은정 | 진세노사이드 및 철분이 보강된 식물성 대체육 첨가물 |
Non-Patent Citations (1)
Title |
---|
ANONYMOUS: "Vegan food for vegans What is meat substitute? Healthy plant-based meat, is it meat or vegetables?", DAILY, 29 March 2019 (2019-03-29), XP055863690, Retrieved from the Internet <URL:https://www.daily.co.kr/life3130145518> * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113017096A (zh) * | 2021-04-30 | 2021-06-25 | 云南爱尔康生物技术有限公司 | 一种含虾青素的植物肉及其制作方法 |
WO2023182330A1 (fr) * | 2022-03-23 | 2023-09-28 | 株式会社ニチレイフーズ | Aliment transformé de substitution de viande, son procédé de production, procédé d'amélioration de la texture de celui-ci, et améliorant de texture pour aliment traité de substitution de viande |
WO2023201048A3 (fr) * | 2022-04-14 | 2023-11-23 | Omeat Inc. | Systèmes et procédés de préparation de viande cultivée et de succédanés de viande à partir de protéines végétales |
Also Published As
Publication number | Publication date |
---|---|
KR102241883B1 (ko) | 2021-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2021225212A1 (fr) | Analogue de viande | |
WO2014171781A1 (fr) | Composition prévenant ou traitant les symptômes de la xylostomiase | |
KR102475666B1 (ko) | 식물성 고기 반죽을 주원료로 하는 푸드 3d 프린팅 | |
WO2010087577A2 (fr) | Utilisation d'extrait de thymus capitatus, d'extrait de satureja hortensis, ou de carvacrol pour traiter des maladies métaboliques | |
WO2017073904A1 (fr) | Procédé de production de nouilles ramen d'orge d'allium hookeri | |
KR101484021B1 (ko) | 울금포함 복합물 추출물을 함유한 면역증강용 조성물 | |
WO2015030336A1 (fr) | Composition contenant un extrait composite de raisin et de schisandra chinensis pour la prévention ou le traitement de maladies associées au syndrome métabolique | |
WO2021080297A1 (fr) | Composition contenant un extrait de fleur d'onagre en tant que principe actif pour prévenir ou traiter l'obésité ou des syndromes métaboliques ainsi induits | |
WO2015064975A1 (fr) | Composition comprenant un extrait de viola herba, ou un extrait de viola herba, persicae semen, cinnamomi ramulus, et glycyrrhiza spp. pour la prévention ou le traitement de maladies cardiovasculaires liées aux lipides et de l'obésité | |
WO2020256464A1 (fr) | Utilisation d'une fraction d'extrait de tubercule d'apios americana ayant une activité anti-inflammatoire comme agent préventif ou thérapeutique de la gastrite alcoolique, et son procédé de production | |
WO2015194809A1 (fr) | Composition à effet immunomodulateur et immunostimulant comprenant un extrait de dendropanax morbifera léveille en tant que principe actif, et son utilisation | |
WO2015167240A1 (fr) | Composition contenant un extrait de scutellaria alpina | |
WO2014065640A2 (fr) | Composition pour le traitement ou la prévention de maladies inflammatoires contenant un extrait de myagropsis myagroides ou fraction de celui-ci comme principe actif | |
WO2022114320A1 (fr) | Procédé de fabrication de collation à base de nouilles pour animaux de compagnie à l'aide de son d'orge fermenté, et collation à base de nouilles fabriquée à l'aide de ce dernier | |
WO2019045467A2 (fr) | Pâte de poisson plat ayant un effet antioxydant et antihypertenseur et procédé de fabrication associé | |
KR102436692B1 (ko) | 견사단백질을 갖는 익힌 누에가공물을 포함하는 비만의 예방 또는 치료용 조성물 | |
KR102263365B1 (ko) | 식물성 고기 | |
WO2012105816A2 (fr) | Composition destinée à prévenir et traiter le diabète et les complications du diabète comprenant une poudre d'amphicarpaea edgeworthii var. trisperma ou un extrait de celle-ci | |
WO2015105373A1 (fr) | Composition pour la prévention ou le traitement de l'asthme, comprenant un extrait de l'e uonymus alatus ou une fraction de ce dernier | |
WO2021112371A1 (fr) | Amuse-gueule, comprenant de l'abalone, pour animal de compagnie et procédé pour sa préparation | |
KR102312675B1 (ko) | 개똥쑥 추출물, 후박 추출물 또는 이들의 혼합 추출물을 포함하는 항염증, 비만 및 비알콜성 지방간 질환의 개선, 예방 또는 치료용 조성물 | |
WO2016204493A1 (fr) | Nouveau composé (ks 513) isolé de pseudolysimachion rotundum var. subintegrum, la composition le comprenant comme ingrédient actif pour la prévention ou le traitement de l'allergie, d'une maladie inflammatoire, de l'asthme ou d'une maladie pulmonaire obstructive chronique et son utilisation | |
WO2015009047A1 (fr) | Composition contenant un extrait de humulus japonicus utilisée dans la prévention ou le traitement de maladies liées à la résistance à l'insuline | |
WO2018066969A1 (fr) | Composition pharmaceutique comprenant de l'arazyme en tant que principe actif pour la prévention ou le traitement d'une maladie métabolique | |
WO2020218733A2 (fr) | Composition pour soulager, prévenir ou traiter l'arthrite, contenant un extrait de feuille de stewartia pseudocamellia et un extrait de feuille de maclura tricuspidata en tant que principes actifs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20934871 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20934871 Country of ref document: EP Kind code of ref document: A1 |